within Pharmacolibrary.Drugs.ATC.A;

model A10AB02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00014000000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10AB02</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Insulin (beef) is a preparation of insulin derived from bovine (cow) pancreas. It was historically used to treat diabetes mellitus for glycemic control before the widespread use of human recombinant insulin. Due to immunogenicity and the availability of human recombinant and analog insulins, beef insulin is rarely used and no longer approved in many countries.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetic parameters are reported for healthy adult volunteers or adult patients with insulin-dependent diabetes mellitus (type 1), after subcutaneous administration.</p><h4>References</h4><ol><li><p>Larkins, RG (1983). Human insulin. <i>Australian and New Zealand journal of medicine</i> 13(6) 647–651. DOI:<a href=\"https://doi.org/10.1111/j.1445-5994.1983.tb02628.x\">10.1111/j.1445-5994.1983.tb02628.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6372774/\">https://pubmed.ncbi.nlm.nih.gov/6372774</a></p></li><li><p>Hildebrandt, P, et al., &amp; Kühl, C (1985). The subcutaneous absorption of human and bovine ultralente insulin formulations. <i>Diabetic medicine : a journal of the British Diabetic Association</i> 2(5) 355–359. DOI:<a href=\"https://doi.org/10.1111/j.1464-5491.1985.tb00650.x\">10.1111/j.1464-5491.1985.tb00650.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2951089/\">https://pubmed.ncbi.nlm.nih.gov/2951089</a></p></li><li><p>Brogard, JM, et al., &amp; Paris-Bockel, D (1985). Genetically engineered insulin: five years of experience. <i>Drugs under experimental and clinical research</i> 11(6) 397–406. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3915289/\">https://pubmed.ncbi.nlm.nih.gov/3915289</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10AB02;
